Integral Ad Science (NASDAQ:IAS) Issues Earnings Results, Beats Expectations By $0.02 EPS

Integral Ad Science (NASDAQ:IAS – Get Free Report) announced its quarterly earnings results on Thursday. The company reported $0.05 earnings per share for the quarter, topping analysts’ consensus estimates of $0.03 by $0.02, Briefing.com reports. Integral Ad Science had a net margin of 4.08% and a return on equity of 2.17%. The firm had revenue of $113.65 million during the quarter, compared to analysts’ expectations of $112.41 million. During the same period in the prior year, the company earned $0.01 EPS. The firm’s revenue was up 13.3% on a year-over-year basis. Integral Ad Science updated its Q3 2023 guidance to EPS.

Integral Ad Science Stock Performance

Shares of NASDAQ:IAS traded down $3.66 during trading on Friday, reaching $15.17. 3,513,383 shares of the company’s stock traded hands, compared to its average volume of 715,956. Integral Ad Science has a 12 month low of $6.63 and a 12 month high of $20.88. The company has a debt-to-equity ratio of 0.26, a current ratio of 4.01 and a quick ratio of 4.01. The stock has a market capitalization of $2.35 billion, a P/E ratio of 157.10 and a beta of 1.61. The company has a 50 day moving average of $18.76 and a 200-day moving average of $15.19.

Analysts Set New Price Targets

A number of equities analysts have commented on the stock. Stifel Nicolaus boosted their price objective on shares of Integral Ad Science from $20.00 to $23.00 and gave the stock a “buy” rating in a report on Friday, July 21st. Benchmark began coverage on shares of Integral Ad Science in a research note on Tuesday, June 6th. They issued a “hold” rating on the stock. Morgan Stanley restated an “overweight” rating and issued a $21.50 target price on shares of Integral Ad Science in a research note on Friday. Piper Sandler upped their target price on shares of Integral Ad Science from $21.00 to $23.00 in a research note on Friday, July 14th. Finally, Barclays upped their target price on shares of Integral Ad Science from $20.00 to $21.00 in a research note on Wednesday, July 19th. Three equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has given a strong buy rating to the stock. Based on data from MarketBeat.com, Integral Ad Science has a consensus rating of “Moderate Buy” and an average target price of $19.68.

Insiders Place Their Bets

In other Integral Ad Science news, major shareholder Vep Group, Llc sold 5,220,000 shares of the company’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $18.13, for a total value of $94,638,600.00. Following the completion of the transaction, the insider now owns 77,660,001 shares in the company, valued at approximately $1,407,975,818.13. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Integral Ad Science news, major shareholder Vep Group, Llc sold 5,220,000 shares of the company’s stock in a transaction dated Thursday, June 15th. The shares were sold at an average price of $18.13, for a total value of $94,638,600.00. Following the completion of the transaction, the insider now owns 77,660,001 shares in the company, valued at approximately $1,407,975,818.13. The transaction was disclosed in a legal filing with the SEC, which is available through the SEC website. Also, insider Tom Sharma sold 9,646 shares of the company’s stock in a transaction dated Monday, May 22nd. The stock was sold at an average price of $17.41, for a total transaction of $167,936.86. Following the completion of the transaction, the insider now owns 45,393 shares of the company’s stock, valued at approximately $790,292.13. The disclosure for this sale can be found here. In the last 90 days, insiders sold 16,756,933 shares of company stock worth $267,781,604. Insiders own 2.00% of the company’s stock.

Institutional Inflows and Outflows

Several institutional investors and hedge funds have recently made changes to their positions in IAS. Wellington Management Group LLP boosted its holdings in shares of Integral Ad Science by 15,557.5% in the first quarter. Wellington Management Group LLP now owns 3,152,174 shares of the company’s stock valued at $43,500,000 after acquiring an additional 3,132,042 shares in the last quarter. Vanguard Group Inc. boosted its holdings in shares of Integral Ad Science by 77.2% in the third quarter. Vanguard Group Inc. now owns 4,752,765 shares of the company’s stock valued at $34,409,000 after acquiring an additional 2,070,907 shares in the last quarter. BlackRock Inc. boosted its holdings in shares of Integral Ad Science by 47.1% in the first quarter. BlackRock Inc. now owns 1,603,564 shares of the company’s stock valued at $22,129,000 after acquiring an additional 513,654 shares in the last quarter. Citadel Advisors LLC boosted its holdings in shares of Integral Ad Science by 109.8% in the third quarter. Citadel Advisors LLC now owns 977,467 shares of the company’s stock valued at $7,077,000 after acquiring an additional 511,667 shares in the last quarter. Finally, Clearbridge Investments LLC lifted its stake in Integral Ad Science by 80.3% during the first quarter. Clearbridge Investments LLC now owns 1,020,067 shares of the company’s stock valued at $14,077,000 after purchasing an additional 454,210 shares during the last quarter. 96.39% of the stock is currently owned by institutional investors.

Integral Ad Science Company Profile

(Get Free Report)

Integral Ad Science Holding Corp. operates as a digital advertising verification company in the United States, the United Kingdom, France, Germany, Italy, Singapore, Australia, France, Japan, and India. The company provides IAS Signal, a cloud-based technology platform that offers return on ad spend needs; and deliver independent measurement and verification of digital advertising across devices, channels, and formats, including desktop, mobile, connected TV, social, display, and video.

See Also

Earnings History for Integral Ad Science (NASDAQ:IAS)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat’s editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Before you consider Integral Ad Science, you’ll want to hear this.

MarketBeat keeps track of Wall Street’s top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on… and Integral Ad Science wasn’t on the list.

While Integral Ad Science currently has a “Moderate Buy” rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Best High-Yield Dividend Stocks for 2023 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

Source link